Tag: Novo
Target: Novo targeting compounded obesity drugs and Amgen ‘at risk’ launchNew Title: Novo Targets...
Hello, everyone! It's great to be here with you today. We hope you're all doing well and ready to dive into some interesting news....
FDA Petitioned to Prevent Compounders from Producing Ozempic Generics
Novo Nordisk, the pharmaceutical company, has requested the Food and Drug Administration (FDA) to stop compounding pharmacies from producing generic versions of its popular...
BREAKING NEWS
Medicare Coverage of Wegovy Should Include, But Not Negotiate Price
Title: Biden Administration's Decision on Wegovy Medicare Coverage Sparks ControversyPresident Biden's recent announcement regarding the Medicare coverage of Wegovy, a GLP-1 obesity medication, has...
